These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9546698)

  • 21. Predominance of lactate dehydrogenase isoenzyme 1 in a patient with bezafibrate-induced rhabdomyolysis.
    Haubenstock A; Schröcksnadel W; Bauer K; Schmidt P; Gabl F
    Clin Chem; 1984 Sep; 30(9):1587-8. PubMed ID: 6467582
    [No Abstract]   [Full Text] [Related]  

  • 22. Morphometry of abnormal peroxisomes induced by withdrawal of bezafibrate, a hypolipidemic drug in male rat hepatocytes.
    Kondo K; Makita T
    J Vet Med Sci; 1997 Apr; 59(4):297-9. PubMed ID: 9152941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of fibrate-induced rhabdomyolysis with plasma exchange in ESRD.
    Yang KC; Fang CC; Su TC; Lee YT
    Am J Kidney Dis; 2005 Mar; 45(3):e57-60. PubMed ID: 15754265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Does hypothyroidism potentialize muscular toxicity of fibrates?].
    Harlé JR; Toussirot E; Disdier P; Drancourt M; Weiller PJ
    Rev Med Interne; 1990; 11(4):336. PubMed ID: 2096444
    [No Abstract]   [Full Text] [Related]  

  • 25. Paradoxical severe decrease in serum HDL-cholesterol after treatment with a fibrate.
    Olukoga AO
    J Clin Pathol; 2002 Sep; 55(9):718. PubMed ID: 12195008
    [No Abstract]   [Full Text] [Related]  

  • 26. [Rhabdomyolysis associated with the use of simvastatin].
    Pinilla Moraza J; Fernández Requena E; Cortes Bejar M; Khalil H
    Rev Clin Esp; 2003 Dec; 203(12):615. PubMed ID: 14622517
    [No Abstract]   [Full Text] [Related]  

  • 27. Cerivastatin and gemfibrozil-associated rhabdomyolysis.
    Bruno-Joyce J; Dugas JM; MacCausland OE
    Ann Pharmacother; 2001 Sep; 35(9):1016-9. PubMed ID: 11573847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bezafibrate-induced myolysis and myoglobinuria in patients with impaired renal function].
    Rumpf KW; Barth M; Blech M; Kaiser H; Koop I; Arnold R; Scheler F
    Klin Wochenschr; 1984 Apr; 62(8):346-8. PubMed ID: 6727274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antilipemic agents, hypothyroidism, and rhabdomyolysis].
    Pía Iglesias G; Garrido Sanjuán JA; González González C; Sesma Sánchez P
    Rev Clin Esp; 2000 Apr; 200(4):236-7. PubMed ID: 10857417
    [No Abstract]   [Full Text] [Related]  

  • 30. Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations.
    Oldemeyer JB; Lund RJ; Koch M; Meares AJ; Dunlay R
    Cardiology; 2000; 94(2):127-8. PubMed ID: 11173785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of rhabdomyolysis and thromboembolic event secondary to fibrate monotherapy.
    Yildiz A; Gucuk E; Cay S
    Acta Cardiol; 2008 Aug; 63(4):515-7. PubMed ID: 18795591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute rhabdomyolysis during treatment with ciprofibrate].
    Delangre T; Vernier L; Moore N; Mihout B
    Presse Med; 1990 Nov; 19(39):1811-2. PubMed ID: 2148009
    [No Abstract]   [Full Text] [Related]  

  • 33. Rhabdomyolysis associated with concurrent use of simvastatin and diltiazem.
    Peces R; Pobes A
    Nephron; 2001 Sep; 89(1):117-8. PubMed ID: 11528245
    [No Abstract]   [Full Text] [Related]  

  • 34. Fenofibrate-induced rhabdomyolysis in two dialysis patients with hypothyroidism.
    Clouâtre Y; Leblanc M; Ouimet D; Pichette V
    Nephrol Dial Transplant; 1999 Apr; 14(4):1047-8. PubMed ID: 10328516
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute renal failure due to fenofibrate monotherapy.
    Usküdar Cansu D; Yaşar NS; Korkmaz C
    Anadolu Kardiyol Derg; 2011 Jun; 11(4):371-2. PubMed ID: 21592934
    [No Abstract]   [Full Text] [Related]  

  • 36. Fenofibrate monotherapy induced rhabdomyolysis.
    Barker BJ; Goodenough RR; Falko JM
    Diabetes Care; 2003 Aug; 26(8):2482-3. PubMed ID: 12882895
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bezafibrate myopathy in two patients with chronic renal failure].
    Inoue M; Jimi T; Machida H; Niwa Y; Wakayama Y
    Rinsho Shinkeigaku; 1992 Jul; 32(7):725-8. PubMed ID: 1291164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the synergistic adverse effects of concomitant therapy with statins and fibrates on rhabdomyolysis.
    Matzno S; Tazuya-Murayama K; Tanaka H; Yasuda S; Mishima M; Uchida T; Nakabayashi T; Matsuyama K
    J Pharm Pharmacol; 2003 Jun; 55(6):795-802. PubMed ID: 12841940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rhabdomyolysis due to simvastatin in a transplant patient: Are some statins safer than others?
    Stirling CM; Isles CG
    Nephrol Dial Transplant; 2001 Apr; 16(4):873-4. PubMed ID: 11274299
    [No Abstract]   [Full Text] [Related]  

  • 40. Rhabdomyolysis with simvastatin and nefazodone.
    Thompson M; Samuels S
    Am J Psychiatry; 2002 Sep; 159(9):1607. PubMed ID: 12202291
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.